Filing Details
- Accession Number:
- 0001645627-17-000106
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-15 14:56:14
- Reporting Period:
- 2017-08-11
- Filing Date:
- 2017-08-15
- Accepted Time:
- 2017-08-15 14:56:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-08-11 | 2,000 | $0.03 | 22,307,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-11 | 2,000 | $0.03 | 22,309,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-11 | 5,000 | $0.03 | 22,314,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-11 | 2,000 | $0.03 | 22,316,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-11 | 2,000 | $0.03 | 22,318,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-11 | 5,000 | $0.03 | 22,323,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-11 | 2,000 | $0.03 | 22,325,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-11 | 2,000 | $0.03 | 22,327,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-11 | 2,000 | $0.03 | 22,329,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-11 | 2,000 | $0.03 | 22,331,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-11 | 2,000 | $0.03 | 22,333,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,700 | $0.03 | 22,336,589 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 300 | $0.03 | 22,336,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,338,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,340,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,342,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,344,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,346,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 5,000 | $0.03 | 22,351,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,353,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,355,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 5,000 | $0.03 | 22,360,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 5,000 | $0.02 | 22,365,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,367,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,369,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,371,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,373,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 2,000 | $0.03 | 22,375,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 11,000 | $0.03 | 22,386,889 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-08-14 | 3,000 | $0.03 | 22,389,889 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |